We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
British & American Investment Trust Plc | BAF | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
21.00 | 20.50 | 21.00 | 20.50 | 21.00 |
Industry Sector |
---|
EQUITY INVESTMENT INSTRUMENTS |
Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
---|---|---|---|---|---|---|
29/09/2023 | Interim | GBP | 0.0175 | 07/12/2023 | 08/12/2023 | 07/12/2023 |
30/09/2022 | Interim | GBP | 0.0175 | 08/12/2022 | 09/12/2022 | 22/12/2022 |
29/09/2021 | Interim | GBP | 0.008 | 11/11/2021 | 12/11/2021 | 09/12/2021 |
27/05/2021 | Interim | GBP | 0.027 | 10/06/2021 | 11/06/2021 | 24/06/2021 |
30/10/2020 | Interim | GBP | 0.027 | 19/11/2020 | 20/11/2020 | 10/12/2020 |
30/09/2019 | Interim | GBP | 0.027 | 21/11/2019 | 22/11/2019 | 12/12/2019 |
Top Posts |
---|
Posted at 07/12/2023 09:22 by plasybryn Dividend day? |
Posted at 13/10/2023 11:14 by plasybryn DividendsWe intend to pay an interim dividend of 1.75 pence per ordinary share for the year to 31st December 2023 on 7 December 2023. This is the same level of dividend as was paid in calendar 2022. A preference dividend of 1.75 pence per preference share will be paid on the same date. This dividend payment represents a yield of approximately 10 percent on the ordinary share price averaged over the first six month period of the year. WHAT IS THE EX DIVIDEND DATE? |
Posted at 12/11/2020 15:57 by plasybryn Why is it doing so well.Ex dividend 19th November |
Posted at 06/11/2020 12:03 by plasybryn DividendWe intend to pay an interim dividend of 2.7 pence per ordinary share on 10 December 2020 to shareholders on the register at 20 November 2020. This represents an unchanged dividend from last year's interim dividend and a yield of approximately 9 percent on the ordinary share price averaged over the period. A preference dividend of 1.75 pence will be paid to preference shareholders on the same date. |
Posted at 23/5/2019 08:43 by topvest The dividend is not sustainable, as flagged in the Chairman's Statement. The dividends have effectively been out of capital for years. High dividend, but significant capital losses. |
Posted at 06/8/2018 11:53 by petewy The spread is ten. 75p to buy but a great divi. Looks tempting. |
Posted at 31/10/2016 18:36 by topvest Yes, this company is priced not to trade. Very expensive versus net assets and dividend yield is totally unsustainable. There will be a devastating loss of capital for anyone buying these shares unless the speculative pharma investments come off in a big way. |
Posted at 25/4/2014 08:21 by topvest Yes, be interesting to see if they continue with the dubious dividend policy next week. |
Posted at 20/1/2014 20:22 by topvest I'm amazed this went so high recently. It's betting the house on a loss making pharma business. They may be lucky and it all comes good, but I think this is a bit of a house of cards until they get their investment strategy sorted out. They should 1. Sell the speculative pharma business whenever they get a decent opportunity and 2. Stop destroying value through buying shares just before they go ex-dividend which is a totally stupid investment strategy and 3. Re-base the dividend as any fool can see that the dividend record is all a bit of a sham and just a return of capital. |
Posted at 22/8/2013 21:59 by coolen I sold out too this year. My reasoning was, as TopVest points out, the high (but uncovered) dividend was sucking-in income investors. I viewed that BAF was merely taking advantage of new rules which allows investment trusts (as approved by the Inland Revenue) to pay dividends with tax credits out of capital. A bizarre decision, in my view, as it gives a false impression of true income receipts. As to BAF's love affair with the sniffy Geron fiasco: why, out of all the stocks in the world, did they choose that one -not only to invest in, but to make it their largest investment ? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions